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The hypothesis that antigen causes population shifts in responding immunocom- 
patent cells through competition among these cells for antigen (1) is in accord with 
the following experimental observations. Antibodies with increased "avidity" for anti- 
gen appear following immunization (2). Ligand affinity of anti-hapten antibody can 
rise  several  orders  of  magnitude  in  serum  samples  taken  a  few weeks apart (3). 
This  increase results  from  synthesis of new molecules with greater affinity for  the 
hapten  (4).  High  affinity antibody appears earlier when  smaller antigen  doses  are 
used for immunization (4). Similarly thymidine incorporation in vitro indicates that 
animals sensitized by low antigen doses yield cells more responsive to low dose chal- 
lenge than do animalssensitized byhigh doses (5). The ability to induce an anamnestic 
anti-hapten response with hapten-heterologous carrier conjugates increases with time 
after sensitization in vivo (6-9)  and correlates with  the appearance  of  high  affinity 
anti-hapten antibody (8-9).  The above evidence, largely contributed by studies  of 
antibody affinity, suggests that antigen brings about a  gradual shift in the specific 
immunocompetent population until late in immunization when it consists mainly of 
cells  bearing  high  affinity receptors and  synthesizing high  affinity antibody  (10). 
This hypothesis assumes that the affinity of a particular antibody for its specific ligand 
reflects the affinity of antigen receptors on the cell which synthesized the antibody. 
However, few attempts have been made to measure directly the cellular changes in 
immunocompetent populations. If, as suggested above, antigen preferentially selects 
responsive cell populations with surface receptors of higher affinity, then later in the 
immune  response  less antigen  should be  required  to  stimulate  these  newly-arising 
cells. Systematic studies of this predicted increase in cellular sensitivity to antigen 
have not yet been described. 
We reported previously that  trinitrophenyl-hemocyanin (TNP-KLH) 1 initiates a 
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vigorous  secondary  anti-hapten  response  in  vitro  (11)  as  detected  by  anti-hapten 
plaque assay  (12). This system offers two main advantages for detecting cell popula- 
tions with increased antigen sensitivity.  (a)  Stimulating the anamnestic response in 
vitro insures  exposure of  the entire immunocompetent  population  to  a  known  con- 
centration  of antigen enabling a  comparison of dose effects.  (b)  Detecting only cells 
synthesizing  anti-TNP  avoids variability  resulting  from additive  responses  to mul- 
tiple, uncharacterized determinants  on complex immunogens. 
Our results indicate that anti-hapten  memory cells with increased sensitivity 
for antigen in vitro arise in vivo following immunization of BALB/c  mice with 
TNP-KLH.  During  a  1-4  month  resting  period  this  sensitivity  to  antigenic 
stimulation in vitro may increase 1000-fold. This result supports  the hypothesis 
that  competition  for  antigen  selects  memory  cells  with  high-afifinity  antigen 
receptors. 
Materials and Methods 
Mice.  -Adult BALB/c female mice were obtained from Simonsen Laboratories, Inc., GiF 
roy, Calif, They were caged in groups of eight with free access  to food and water. The mice 
were first immunized when 2-5 months old. 
Proteins.--Hemocyanin  (KLH) was obtained from keyhole limpets (Megathura crenulata) 
by the method  of Campbell, et al.  (13).  TNP-KLH was prepared  as described previously 
(14). Mole ratios of TNP:KLH ranged from TNP850KLH to TNPI000KLH. The particulate 
form of antigen was prepared by coating TNP-KLH onto bentonite (T-K-B) as described pre- 
viously (12).  Trinitrophenyl-bovine serum  albumin  (TNP-BSA)  was  prepared  as in refer- 
ence 14. It had a TNP:BSA mole ratio of TNP15BSA. 
Spectrophotometric determinations  of hapten:protein  ratios  were performed as in refer- 
ence  14.  Protein  was  determined  by  nesslerization  (13). 
Immunization.--Mice  were primed for  later secondary in  vitro stimulation by intraperi- 
toneal injections of T-K-B every 2 wk for a  total of three injections. Each injection contained 
100 #g protein in 0.5 ml saline. 
Cell Culture.--Mice were rested  1-4 months after priming, killed by cervical dislocation, 
and their dissociated spleen cells cultured to detect antigen-sensitive memory cells. To mini- 
mize individual variation between mice, spleen cells from at least three mice were pooled in 
each experiment. Cells were cultured and harvested for plaque assay by the method of Mishell 
and Dutton  (15) as described  earlier  (11). Each  culture  contained  i-1.5  X  107  nucleated 
spleen cells.  Cells were counted on a Coulter Counter. Culture medium contained 10% fetal 
calf serum ("Rehatuin" E21505  Reheis Co., Inc., Berkley Heights,  N.  J.) and 50 Units/ml 
each of penicillin and streptomycin (Microbiological Associates,  Inc., Bethesda, Md.). Experi- 
mental groups cultured in vitro received various concentrations of soluble TNP-KLH antigen 
or particulate T-K-B antigen as indicated in Results.  We reported previously that similar 
protein  concentrations  of  soluble  or particulate  TNP-KLH  induce comparable  secondary 
responses  in vitro (11). Control groups did not receive antigen. Antigen was added at initiation 
of culture (day 0). 
Detection of In  Vitro AntI-TNP Response: Anti-TNP Plaque Assay.--TNP-haptenated 
sheep red blood cells (TNP-SRBC) were prepared according to the method of Rittenberg and 
Pratt  (12). Cultured cells were scraped from the culture dishes and packed by centrifugation 
(11);  culture  supernatants  were removed for separate  analysis.  Cells  were resuspended  in 
appropriate volumes (1-4 ml) of cold Eagle's minimal essential medium, counted, and plated 
in quadruplicate with TNP-SRBC and with nonhaptenated SRBC (N-SRBC). The responses 928  IN  VITRO  ANTI-TNP  RESPONSE:  INCREASING  CELL  AVIDITY 
are reported as anti-TNP plaque-formlng ceils  (PFC)/106 cells assayed.  A low background 
plaque count was obtained with N-SRBC  (<18  PFC/106). 
Cultures were tested for cells  producing IgM and  IgG antibodies  (11).  Cells  producing 
IgM anti-TNP  antibody  were detected  by direct plating.  Cells  producing  IgG anti-TNP 
antibody were detected  by adding  rabbit  or goat anti-mouse globulin antiserum  with  the 
complement.  Our  facilitation  serum  inhibits  19S  PFC  approximately  25-30%;  therefore, 
total facilitated plaques were taken as 7S PFC  (12, 16). Guinea pig serum diluted 1:20 was 
used for complement. Guinea pig serum and anti-globulin serum were absorbed with SRBC 
prior to use (12). The anti-globulin serum was heated at 56°C for 30 rain prior to use. 
Supernatant Titration.--The lytic spot test of Hfibner and  C,-engozian (17) was modified 
to titer small amounts of anti-TNP antibody in culture supernatants.  Soft agar layers con- 
taining 0.47% TNP-SRBC or N-SRBC were used. Drops of diluted supernatant were placed 
on these layers, allowed to soak in, and incubated for 1 hr at 37°C, after which the plates were 
developed as in the anti-TNP  plaque assay.  Supernatant  samples were treated  with 0.1 
2-mercaptoethanol  for 30  rain  at  37°C,  dialyzed  against  0.01  ~  iodoacetamide,  and  then 
against 0.85% saline (18). Lyric spot testing was then used to determine the presence of 19S 
and 7S antibody in the supernatant. 
14C Arn~na Acid Incorporation.--Cultures were tested for protein synthesis  by adding  1 
#Ci each of 14C isoleucine and 14C valine to cultures on day 4. Supernatants were concentrated 
by incubation with polyacrylamide gel (Lyphogel,  LKB Instruments,  Inc., Rockville, Md.). 
14C amino acid incorporation in total supernatant  protein was estimated by the method of 
Timourian and Denny as described in reference 19. The supernatants were dialyzed against 
three changes  of buffered saline prior  to adsorption  on chromatography paper strips.  The 
protein was precipitated on the strips with 10% trichloracetic acid. Duplicate samples were 
prepared and the counts averaged after subtraction of background. Background was approxi- 
mately 1% of the total counts. Incorporation of 14C-amino acids into specific anfi-TNP was 
determined by adding TNP-BSA and anti-BSA to sixfold concentrated culture supernatants. 
Antigen-antibody precipitates were allowed to form at 37°C for 1 hr followed by 4°C for 3 
days.  The precipitates were then washed  twice in cold saline,  digested in NCS  (Nuclear- 
Chicago Corp.,  Des Plaines, Ill.), and counted in a  Beckman Liquid  Scintillation  Counter 
(Beckman  Instruments,  Inc.,  Fullerton,  Calif.). 
Radioimmunoelectrophoresls.--The method  of Thorbecke  and  Hochwald  (20) was  used. 
Culture supernatants were concentrated threefold and electrophoresed with unlabeled mouse 
serum containing anti-TNP antibody. Following electrophoresis TNP-BSA, TNP-KLH, BSA, 
and KLI-I were used  to  develop precipitates.  Radioautographs  were  prepared  on  Kodak 
RPS negative film and exposed  for 2 months. 
RESULTS 
Early Secondary Anti-TNP Response In Vitro.--Spleen cell suspensions  were 
placed in culture with 0.2 or 0.02 ttg protein TNP-KLH  (particulate or soluble) 
6-7  wk following the  last  in  vivo injection  of  T-K-B.  (See  Fig.  1  for general 
method).  The number of cells synthesizing anti-TNP at the start of the culture 
and  during  the  period  of  maximum  response  (days  3-6)  is  shown  in  Fig.  2. 
The number  of cells producing  7S antibody is compared with the number pro- 
ducing  19S  antibody.  The  higher  antigen  dose  suppressed  the  7S  response 
60%,  whereas  19S  stimulation  occurred  equally  from  both  doses.  Primary 
responses  of  this  magnitude  have  not  occurred  under  similar  circumstances 
in our laboratory,  indicating that  the  19S response  is a  secondary one. A  small WESLEY  W.  BULLOCK AND  MARVIN  B.  RITTENBERG  929 
increase  in  cells  producing  anti-TNP  occurred  in  control  cultures  (<100), 
possibly  due  to  release  of  sequestered  antigen  (21).  Experiments  using  un- 
haptenated  carrier  protein  as  antigen  did  not  induce  an  anti-TNP  response 
greater than that in control cultures.  In addition,  cells did not produce anti- 
TNP if heat-killed at 56°C for 30 rain (22),  if DNA synthesis was blocked by 
10  -5 M methotrexate (23),  or if protein synthesis was blocked by the addition 
of  100 #g chloramphenicol/culture  at day 0  (24).  The change in response ob- 
tained  by challenge  with  0.02  ~g  TNP-KLH  at  intervals  throughout  the  4 
month  period  studied  is  shown in  Fig.  3.  The  general shape of  the  response 
FIG. 1. Outline of culture method used to determine antigen sensitivity of memory cell 
population. TNP-KLH was injected or added to cultures in micrograms of protein  (P)  as 
described in the text. 
curve was similar for all antigen doses tested,  but peak memory varied with 
challenge dose. 
Antibody  Synthesis  In  Vitro.--Anti-TNP  was  detected  in  unconcentrated 
culture  supernatants  on  day  6  at  end  point  dilutions  of  1:512  in  antigen- 
stimulated cultures  and  1:32  in  controls using the lytic spot test.  Mercapto- 
ethanol treatment removed 19S lyric activity, but left lyric activity detectable 
by anti-mouse IgG unaltered.  14C labeled amino acids were used to determine 
in vitro synthesis of antibody. Table I  compares the ability of antigen-stimu- 
lated and control cultures to form plaques and to incorporate 14C isoleucine and 
14C valine into protein and specific anti-TNP antibody. Antigen stimulation in 930  IN  VITRO  ANTI-TNP  RESPONSE:  INCREASING  CELL  AVIDITY 
vitro resulted in a  27-fold increase in anti-TNP PFC. It also caused a  16-fold 
increase in the incorporation of 14C label into anti-TNP, as compared to non- 
stimulated  cultures.  Antigen-stimulated and  control  cultures  incorporated 
approximately equal amounts of 14C label into total protein. Fig. 4 shows radio- 
immunoelectrophoretic patterns  of  threefold  concentrated,  dialyzed  super- 
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FIO. 2. Increase in cells producing anti-TNP antibody after in vitro initiation of secondary 
immune response. Cells were placed in culture 6-7 wk after primary immunization. Antigen 
was added to cultures at day 0. Either soluble or particulate TNP-KLH was used and the 
results were treated  together, since at the same concentration both forms were shown pre- 
viously to induce similar responses (11). Antigen added: 0.2 #g protein/eulture C)--©; 0.02 
#g protein/culture •  •. The response was evaluated by anti-TNP plaque assay (12). 
Backgrounds resulting from primary stimulation have been subtracted  (7S  <201  PFC/106, 
19S < 190 PFC/106). Each point represents the mean of duplicate cultures (plated in quadru- 
plicate) from four separate experiments; therefore, n  =  8 except for day 4 and day 5 (0.02 
/zg 7S) where n  =  7. Vertical bars represent 95% confidence intervals. 19S response was de- 
tected by direct plating. 7S response was detected by facilitation with antiglobulin serum (12). 
natant from  antigen-stimulated cultures.  The  patterns  indicate  14C  labeled 
anti-TNP antibody in the  supernatant. Labeled  antibody was  not apparent 
against either unhaptenated carrier.  A  more  intense line developed with  the 
haptenated homologous carrier protein (TNP-KLH) than with the haptenated 
heterologous protein (TNP-BSA), suggesting antibody against TNP-modified 
KLH. 
7S  Response:  Time Dependent Development of Increased Cell Sensitivity  to 








lO00  5 
m,. 
4  6  8  10  12  14  16 
WEEKS  BETWEEN  PRIMING  AND  CULTURE 
FIG, 3. Change in secondary responsiveness  to a single antigen dose with time after priming. 
Culture and assay as described in Fig. 2. TNP-KLH (0.02 #g protein) added on day 0 of cul- 
ture. Plaque assay on day 5. Bar-enclosed numbers indicate number of individual experiments. 
Each experiment utilized duplicate cultures plated in quadruplicate. The height of each bar 
represents the mean. 
creased  sensitivity to  antigen during the  postpriming period.  Six wk  and  18 
wk after the last in vivo injection of priming antigen, sets of mice were killed 
and their spleen cells placed in culture with log dilutions of  antigen. The 7S 
anti-TNP PFC response obtained to  each  dose  on day 5  is shown in Fig. 5. 
TABLE  I 
Correlation of Secondary A nti-TNP Immune Response In Vitro.* Comparison of Plaque Assay 
and Incorporation of 14C Isoleucine and I4C Valine into Antibody 
Culture tested  +  Antigen  -  Antigen 
7S PFC/10  s cells  1680  62 
Net CPM in supernatant protein  3250  3428 
Net CPM precipitated from supernatant:~ by TNP-BSA and  491  30 
Anti-BSA 
* Spleen cell response to 0.002 pg P TNP-KLH; assay on Day 5. 
:~ Supernatant protein after concentration, 5.5 mg ~l/ml. 932  IN  VITRO ANTI-TNP  RESPONSE:- INCREASING  CELL AVIDITY 
FIG. 4.  Radioimmunoelectrophoretic demonstration of  anti-TNP  in  supernatants from 
antigen-stimulated cultures. Supernatants were obtained and pooled on day 6 of culture and 
concentrated threefold prior to eleetrophoresis with unlabeled mouse anti-TNP-KLH anti- 
serum as carrier. One #Ci each of 14C isoleucine  and 14C lysine was added to cultures 48 hr 
before assay. Cultures were stimulated by 0.002/~g TNP-KLH on day 0. 
The  experiments  indicated:  (a)  The  number  of  antibody-forming  cells  in- 
duced at 18 wk was one-half that at 6 wk. (b) Concentrations of antigen greater 
than those yielding maximum stimulation suppressed the response. The 18 wk 
culture was suppressed by lower antigen concentrations than the 6 wk culture. 
(c)  Cells  cultured soon after in vivo priming responded to a narrower range of 
antigen dose than cells cultured 12 wk later. (d)  Cell sensitivity to antigen in- 
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FIG. 5. Shift in anti-TNP memory cell sensitivity to antigen dose with time. Culture con- 
ditions and assay as in Fig. 2. Values are means of 7S anti-TNP PFC from duplicate cultures 
assayed in  quadruplicate on day 5  of culture.  Cells  placed in culture 6  wk after priming 
(0----0);  18 wk after priming ((D---©). WESLEY  W.  BULLOCK  AND  MARVIN  B.  RITT~ENBERG  933 
creased with  time in vivo with maximum stimulation of 18-wk cells possible 
with  1000-fold  less  antigen  than  that which  maximally stimulated  the 6  wk 
group.  To further  investigate  this  latter  point  a  series  of  experiments were 
conducted  during  the  6--18 wk period  after priming.  These  experiments  are 
summarized in  Fig.  6  which  reveals  the  continual  development of increased 
memory-cell sensitivity during the 6-18 wk period after priming. The ratio of 
response  (low  TNP-KLH  dose/high  TNP-KLH  dose)  is  given  for  each  of 
eight sequential experiments. The change in ratio with time is due to increasing 
effectiveness of the lower antigen  dose.  Cell cultures from 6  wk postpriming 
mice were twice as responsive to the high antigen dose; however, by 10 wk both 
2.0. 
2.0. 
~  1.5, 
~  1.0 
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FI6. 6. Temporal transition in memory-cell  sensitivity to high and low antigen doses. Rela- 
tive shift in maximum anti-TNP response. Ratio of 7S response to 0.002 #g TN]P-KLH/0.02 
#g TNP-KLH. Each point is the mean of two cultures assayed on day 5 and plated in quadru- 
plicate. Culture conditions and assay as in Fig. 2. 
concentrations  were  equally  effective and  by  12  wk  the  response  was  com- 
pletely reversed with  the  low dose  twice  as  effective as  the high  dose.  This 
transition in antigen sensitivity at these doses ceased at 12 wk. This cessation 
appeared to result from further increases in cell sensitivity concomitant with 
suppression by higher,  previously sfimulatory doses.  A  similar transition was 
obtained with  10-fold higher  antigen  concentrations  (Table II). 
19S  Response: Increasing Antigen  Sensitivity.--A  more  limited  change  in 
antigen  sensitivity was  observed with  cells  synthesizing  19S  anti-TNP.  19S 
responses at two periods after priming are given in Table II. Cells tested early 
after priming were twice as responsive to the higher antigen dose.  It is of in- 
terest  that  the  19S  response of  cells  to  low  antigen  concentration  remained 
constant  between  the  observed periods  whereas  the  7S  response  to  the  low 
antigen dose during the same interval decreased, indicating the suppression of 934  IN  VITRO  ANTI-TNP  RESPONSE:  INCREASING  CELL  AVIDITY 
7S  cells  through  increased  sensitivity  to  antigen.  In  the  early  period  IgM 
memory  cells responded  better  to  10  times  the  antigen  concentration  which 
stimulated maximum  IgG responses  (Table II). 
DISCUSSION 
It  is  clear  from  the  results  that  the  antigen  dose  giving maximum  recall 
depends  on  the interval between  in vivo priming and  in vitro  challenge. Al- 
though  Iv~nyi and  12ern)~ indicated recently (25)  that  antigen  dose is  a  key 
factor  in  the  immune  response,  few  systematic  studies  relate  challenge-dose 
effectiveness with  time  after priming.  It has  been  established that  there  i~ a 
critical  time  after  priming  in  which  a  given  challenge  dose  will  produce  a 
TABLE II 
In Vitro Anti-TNP Response to 0.2 #g P  TNP-KLH and 0.02 #g P  TNP-KLH* During  two 
Intervals  after Priming 
Period after priming  21-52 Days  7093 Days 
Antigen concentration  0.2 #g P  0.02 #g P 
Mean* PFC/106  7S  1106 4-  346  2029 4-  396 
spleen cells  19S  695  4-  190  548  4-  150 
0.2/~g P  0.02 #g P 
433  4-  209  972  4-  209 
354  4-  134  518  4-  139 
PFC 0.02 #g P  7S  1.83  2.24  Ratio: PFC 0.2 vg P  19S  0.79  1.5 
* Culture conditions and assay as in Fig. 2. Cells assayed on day 5 of culture. 
:~ Mean of n cultures plated in quadruplicate -4- 95%  confidence interval, where n  =  16 
for 0.2/~g P, n  =  15 for 0.02 #g P  (days 21-52);  n  =  11 for 0.2 #g P, n  =  10  for 0.02 #g 
P  (days 70-93).  Maximum  19S  background from  primary stimulation was  102  PFC/106 
in the 21-52 day period and 160 PFC/106 in the 70-93 day period. There was no detectable 
7S background. 
maximum anamnestic  response  (26)  and  that less antigen is required for sec- 
ondary than for primary stimulation (27,  28).  These in vivo and  in vitro ob- 
servations suggested changes in the immune memory cell population but did 
not  reveal whether  these  changes were  quantitative  or qualitative. Our  data 
illustrate both  aspects.  The  memory cell population increases to  a  maximum 
and then declines in numbers but at the same time continues to change quali- 
tatively as reflected by increasing sensitivity to lower doses. Paul, Siskind, and 
Benacerraf  were  unable  to  detect  a  consistent change  in  avidity for  antigen 
leading  to  thymidine  incorporation in  cells harvested for  culture  either  7-19 
days  or  5-7  months  after  immunization  (5).  In  contrast  Valantov~,  I~ern~, 
and Iv~nyi reported that the dose of human serum albumin required to give a 
maximum IgG serum titer at 16 wk after priming was 1/10 that required at 6 
wk (29).  However,  similar increased sensitivity was not observed with SRBC WESLEY  W.  BULLOCK AND  MARVIN  B.  RITTENBERG  935 
antigens after longer rest periods (30). Our results concur with and expand the 
findings of Valantov/t et al. as can be seen in Figs. 5  and 6  and in Table II. 
Those animals which were rested longer developed memory cells requiring less 
antigen in culture both for detectable threshold stimulation and for maximum 
stimulation. 
Our  ability to detect these changes may result from limiting  the  assay to 
anti-TNP PFC and/or the in vitro conditions. This in vitro model eliminates 
such in vivo complications as cell migration, antigen dilution, and catabolism 
or localization of antigen outside of immune  tissue; however, it exposes the 
same tissue to antigen-antibody complexes which could be eliminated in vivo 
(31). Washing cultures at 24 or 72 hr after initiation to remove these complexes 
did not alter the results (32). Our data probably reflect in vivo processes since 
the 7S and 19S responses obtained in vitro are similar in size and kinetics to in 
vivo anti-TNP responses (12). The large IgG response obtained is  typical of 
secondary  responses.  Earlier  studies  questioned  the  development  of  IgM 
memory (33,  34);  however, subsequent reports have confirmed its  existence 
(35-37). Our data confirm that IgM memory is reflected by an increase in the 
number of cells  synthesizing antibody (37). 
Passive release rather than synthesis has been reported to cause false plaques 
(38). Heat-killed cells in our experiments did not produce plaques,  although 
the temperature used (56°C for 30 rain) does not affect antibody; this indicates 
that the plaques did not result from release of passively adsorbed antibody. 
Furthermore,  labeled  anti-TNP  recovered  with  TNP-BSA-anti-BSA  pre- 
cipitates  and  also  detected  with  radioimmunoelectrophoresis  demonstrates 
that antibody was synthesized in vitro. 
Dose-response curves such as those shown in Fig. 4  are similar to those ob- 
tained by M~kela  and  Mitchison in vivo when studying  the  suppression  of 
anti-albumin memory cells in  irradiated hosts  (39).  Failure  of some investi- 
gators to detect suppressive effects with high antigen doses may have been due 
to overlapping optimum concentrations of the determinants  on complex im- 
munogens used to follow the immune response (40). The suppression of in vitro 
anti-TNP responses by high antigen doses, as we have noted previously (32), 
resembles high zone immunological tolerance described by others for a variety 
of antigens in vivo and for flagellin and endotoxin in vitro (41-43).  Further 
data  concerning  in  vitro  tolerance  to TNP  are  being  reported  separately  2 
The decline in the size of the memory cell population with time depicted in 
Figs. 3 and 5 has been observed in vivo by Friedman (44) who proposed either 
loss  of memory cells or temporary inhibition of memory resulting from anti- 
body "feedback." Actual decline in memory cell numbers is more likely since, 
2 Rittenberg, M. B., and W. W. Bullock.  In vitro initiated secondary  anti-hapten response. 
III. Specific anti-hapten tolerance induced in vitro. In preparation. 936  IN  VITRO  ANTI-TNP  RESPONSE:  INCREASING  CELL  AVIDITY 
in the in vitro experiments described here, cells were washed prior to culture 
and  antibody titers  in both  stimulated and control cultures  were  relatively 
low. Loss of memory may have resulted from prior irreversible suppression by 
antibody in vivo. 
With time there were fewer anti-TNP memory cells but memory cells with 
increased sensitivity for antigen. This leads us to conclude that only that por- 
tion of the memory cell population with high sensitivity for antigen continued 
to  develop under  in vivo  antigen selection.  Although we  did not assay for 
in vivo KLH, it has been detected in rabbits 1 yr after injection (31). Further- 
more, persistent stimulation by KLH was required for mouse anti-KLH mem- 
ory cell development to continue for 30 days after priming (45). Consequently 
we interpret the results of challenge to reflect continual presence of and selec- 
tive pressure by persisting immunogen. This conclusion is of theoretical interest 
because of the role of receptor affinity in the cell selection model proposed in 
recent years (1,  10, 46).  This model was based on observations that with time 
after hapten immunization, the serum contained antibody of higher affinity. 
The model consists of the following proposals: (a)  that cells are stimulated by 
contact with antigen above a threshold concentration which is related directly 
to the affinity of the resultant antibody (1) ; (b) that each cell and/or its progeny 
make antibody of only one affinity (1, 47) ; and (c) that competition for dimin- 
shing concentrations of antigen results  in  the selection of cells  synthesizing 
high affinity antibody (1)  and/or nonsynthesizing helper cells  implicated by 
cell interaction studies  (48-52).  It is  possible  that such helper  cells  possess 
similar receptor sites and also undergo antigen-selected proliferation. 
Most  experiments  supporting  the  antigen  selection  model  have  utilized 
changes detected in the affinity of the antibody produced rather than on direct 
demonstration of the development of cells with increased sensitivity to antigen. 
The  temporal  increase  in  in  vitro  inductive  capacity  of  lower  TNP-KLH 
doses reported here provides direct cellular evidence for development of cells 
with increased avidity for antigen, most likely reflecting the selective pressure 
of persisting antigen in vivo. 
SUMMARY 
Decreasing antigen in vivo may preferentially stimulate cells with the poten- 
tial for synthesis of high-affinity antibody through activation of surface re- 
ceptors with similarly high affinity. This selection should result in cells with 
increased sensitivity to lower antigen concentrations, cells with greater avidity 
for antigen. We have followed the in vivo changes in anti-TNP memory-cell 
sensitivity by  initiating  the  secondary  anti-hapten  response  in  vitro.  This 
response  was  determined  by  anti-TNP  plaque  assay.  The  results  indicate 
that cell populations with increased sensitivity for antigen continue to emerge 
with time after priming and that this sensitivity may increase 1000-fold in a 4 WESLEY  W.  BULLOCK AND  MARVIN  B.  RITTENBERG  937 
month period.  Increased sensitivity  to stimulation by antigen  is  concomitant 
with  suppression by higher,  previously sfimulatory doses  as in high zone im- 
mune  tolerance.  The  data  support  the  hypothesis  that memory cells  of high 
avidity result from the selective pressure  of diminishing  in vivo antigen  con- 
centration. 
We wish to thank Miss K. Pratt for her valuable technical assistance and J. Jennings, S. 
Edney, and Dr. B. Iglewski for their helpful discussions. 
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